|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3901855A
(en)
|
1974-08-07 |
1975-08-26 |
Us Air Force |
Preparation of polybenzimidazoles
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4227437A
(en)
|
1977-10-11 |
1980-10-14 |
Inloes Thomas L |
Frequency detecting apparatus
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4403607A
(en)
|
1980-05-09 |
1983-09-13 |
The Regents Of The University Of California |
Compatible internal bone fixation plate
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
JPS6135934A
(ja)
|
1984-07-30 |
1986-02-20 |
Tokyo Gas Co Ltd |
管路の内張り方法
|
|
JPS6145145A
(ja)
|
1984-08-07 |
1986-03-05 |
Aisin Warner Ltd |
自動変速機
|
|
JPS61113060A
(ja)
|
1984-11-08 |
1986-05-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
DE3825041A1
(de)
|
1988-07-20 |
1990-02-15 |
Schering Ag |
Pyrido(3,2-e)(1,2,4)triazolo(1,5-a)pyrimidin- 2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, pflanzenwachstumsregulierender und fungizider wirkung
|
|
DE3924424A1
(de)
|
1989-07-24 |
1991-01-31 |
Boehringer Mannheim Gmbh |
Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
|
|
JPH04364168A
(ja)
|
1990-08-08 |
1992-12-16 |
Taisho Pharmaceut Co Ltd |
スルホンアミドピリジン化合物
|
|
ATE167473T1
(de)
|
1990-08-20 |
1998-07-15 |
Eisai Co Ltd |
Sulfonamid-derivate
|
|
US6159686A
(en)
|
1992-09-14 |
2000-12-12 |
Sri International |
Up-converting reporters for biological and other assays
|
|
US5514555A
(en)
|
1993-03-12 |
1996-05-07 |
Center For Blood Research, Inc. |
Assays and therapeutic methods based on lymphocyte chemoattractants
|
|
US5571775A
(en)
|
1994-07-11 |
1996-11-05 |
Dowelanco |
N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
|
|
NZ331941A
(en)
|
1996-02-22 |
2000-04-28 |
Tularik Inc |
Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis
|
|
US5780488A
(en)
|
1996-04-03 |
1998-07-14 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
ATE360689T1
(de)
|
1996-09-10 |
2007-05-15 |
Kocher Theodor Inst |
Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
|
|
AR015104A1
(es)
|
1996-11-13 |
2001-04-18 |
Dowelanco |
Compuestos de n-arilsulfilimina sustituidos, utiles como catalizadores en la preparacion de compuestos de n-arilarilsulfonamida; proceso para preparar dichos compuestos y su uso para catalizar dicha preparacion.
|
|
US6322901B1
(en)
|
1997-11-13 |
2001-11-27 |
Massachusetts Institute Of Technology |
Highly luminescent color-selective nano-crystalline materials
|
|
US6207392B1
(en)
|
1997-11-25 |
2001-03-27 |
The Regents Of The University Of California |
Semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
|
US5990479A
(en)
|
1997-11-25 |
1999-11-23 |
Regents Of The University Of California |
Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
|
GB9803228D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
|
EP0937711A1
(de)
|
1998-02-18 |
1999-08-25 |
Roche Diagnostics GmbH |
Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
|
|
JP4327915B2
(ja)
|
1998-03-30 |
2009-09-09 |
株式会社デ・ウエスタン・セラピテクス研究所 |
スルフォンアミド誘導体
|
|
US6306610B1
(en)
|
1998-09-18 |
2001-10-23 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
US6326144B1
(en)
|
1998-09-18 |
2001-12-04 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
US6251303B1
(en)
|
1998-09-18 |
2001-06-26 |
Massachusetts Institute Of Technology |
Water-soluble fluorescent nanocrystals
|
|
US6380206B1
(en)
|
1998-11-23 |
2002-04-30 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivatives
|
|
JP2000159665A
(ja)
|
1998-11-27 |
2000-06-13 |
Nippon Kayaku Co Ltd |
リウマチの予防または治療剤
|
|
AUPP796798A0
(en)
|
1998-12-30 |
1999-01-28 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
EP1418175A1
(en)
|
1999-06-28 |
2004-05-12 |
Janssen Pharmaceutica N.V. |
Respiratory syncytial virus replication inhibitors
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
JP2001089412A
(ja)
|
1999-09-22 |
2001-04-03 |
Otsuka Pharmaceut Co Ltd |
ベンゼン誘導体またはその医薬的に許容される塩
|
|
AU2001243158A1
(en)
|
2000-02-18 |
2001-08-27 |
Merck And Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
JP2001335714A
(ja)
|
2000-03-22 |
2001-12-04 |
Fuji Photo Film Co Ltd |
アゾ色素、その製造方法、インクジェット用インク、インクジェット記録方法
|
|
US6525051B2
(en)
|
2000-03-27 |
2003-02-25 |
Schering Aktiengesellschaft |
N-heterocyclic derivatives as NOS inhibitors
|
|
AU2001268711A1
(en)
|
2000-06-23 |
2002-01-08 |
Bristol-Myers Squibb Pharma Company |
Heteroaryl-phenyl substituted factor xa inhibitors
|
|
JP3699910B2
(ja)
|
2000-10-31 |
2005-09-28 |
株式会社東芝 |
データ伝送装置、データ伝送方法及びプログラム
|
|
US7468253B2
(en)
|
2001-06-07 |
2008-12-23 |
Chemocentryx, Inc. |
Method for multiple chemokine receptor screening for antagonists using RAM assay
|
|
ATE347695T1
(de)
|
2001-06-07 |
2006-12-15 |
Chemocentryx Inc |
Zellwanderungsassay
|
|
JP2003040726A
(ja)
|
2001-07-26 |
2003-02-13 |
Daito Kasei Kogyo Kk |
化粧料
|
|
EP1453516A2
(de)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
AU2002358390A1
(en)
|
2001-12-18 |
2003-06-30 |
Astrazeneca Ab |
Novel compounds
|
|
US7119112B2
(en)
|
2002-02-28 |
2006-10-10 |
Icagen, Inc. |
Sulfonamides as potassium channel blockers
|
|
AU2003220401A1
(en)
|
2002-03-18 |
2003-10-08 |
Bristol-Myers Squibb Company |
Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
|
|
AU2003248549B2
(en)
|
2002-05-24 |
2010-04-08 |
Millennium Pharmaceuticals, Inc. |
CCR9 inhibitors and methods of use thereof
|
|
US20070021466A1
(en)
|
2002-11-18 |
2007-01-25 |
Solomon Ungashe |
CCR2 inhibitors and methods of use thereof
|
|
US20060111351A1
(en)
|
2002-11-18 |
2006-05-25 |
Solomon Ungashe |
Aryl sulfonamides
|
|
AU2003298661B2
(en)
|
2002-11-18 |
2007-05-10 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7227035B2
(en)
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
US20060100245A1
(en)
|
2002-12-19 |
2006-05-11 |
Neurogen Corporation |
Substituted biphenyl-4-carboxylic acid arylamide analogues
|
|
ES2401079T3
(es)
|
2002-12-20 |
2013-04-16 |
Amgen Inc. |
Moduladores del asma y de la inflamación alérgica
|
|
WO2004058265A1
(en)
|
2002-12-24 |
2004-07-15 |
Biofocus Plc |
Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors
|
|
WO2004099127A1
(en)
|
2003-05-07 |
2004-11-18 |
Novo Nordisk A/S |
Novel compounds as kinase inhibitors
|
|
CA2526385C
(en)
|
2003-05-29 |
2008-07-22 |
Abbott Laboratories |
Continuous dosing regimen with abt-751
|
|
WO2005004810A2
(en)
|
2003-07-02 |
2005-01-20 |
Merck & Co., Inc. |
Arylsulfonamide derivatives
|
|
GB0322016D0
(en)
|
2003-09-19 |
2003-10-22 |
Merck Sharp & Dohme |
New compounds
|
|
US20080187508A1
(en)
|
2004-09-08 |
2008-08-07 |
Boys Town National Research Hospital |
Treatment of Golmerular Basement Membrane Disease Involving Matrix Metalloproteinase-12
|
|
AU2006204750C1
(en)
|
2005-01-14 |
2012-11-01 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
MY153898A
(en)
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
JP4364168B2
(ja)
|
2005-07-11 |
2009-11-11 |
アルゼ株式会社 |
遊技機
|
|
WO2007014054A2
(en)
|
2005-07-22 |
2007-02-01 |
Glaxo Group Limted |
Benzenesulfonamide inhibitor of ccr2 chemokine receptor
|
|
WO2007014008A2
(en)
|
2005-07-22 |
2007-02-01 |
Glaxo Group Limted |
Benzenesulfonamide inhibitor of ccr2 chemokine receptor
|
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
|
US20070219245A1
(en)
|
2006-03-14 |
2007-09-20 |
Cuifen Hou |
Method of use for substituted dipiperidine ccr2 antagonists
|
|
WO2008008394A1
(en)
|
2006-07-12 |
2008-01-17 |
Transform Pharmaceuticals, Inc. |
Tizanidine succinate salt forms and methods of making and using the same
|
|
US20100234364A1
(en)
|
2006-07-14 |
2010-09-16 |
Arindrajit Basak |
Ccr2 inhibitors and methods of use thereof
|
|
US8519135B2
(en)
*
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
CA2692761C
(en)
|
2007-07-12 |
2013-04-30 |
Chemocentryx, Inc. |
Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
|
|
CN102239180B
(zh)
|
2008-08-18 |
2014-12-31 |
辉瑞大药厂 |
抗ccr2抗体
|
|
TW201041888A
(en)
|
2009-05-06 |
2010-12-01 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
PL2513093T3
(pl)
|
2009-12-17 |
2015-03-31 |
Centrexion Therapeutics Corp |
Nowi antagoniści receptora CCR2 i ich zastosowanie
|
|
EP2368876A1
(en)
*
|
2010-03-01 |
2011-09-28 |
Sanofi |
Derivatives of aminoindanes, their preparation and their application in therapeutics
|
|
CN103328479A
(zh)
*
|
2010-09-27 |
2013-09-25 |
普罗克斯马根有限公司 |
7-羟基-吡唑并[1，5-a]嘧啶化合物及其作为ccr2受体拮抗剂的用途
|
|
CA2821985C
(en)
*
|
2011-01-11 |
2019-07-09 |
Dimerix Bioscience Pty Ltd |
Combination therapy
|
|
EP3065744B1
(en)
|
2013-11-04 |
2021-04-21 |
Noxxon Pharma AG |
A ccl2 antagonist for use in treating proteinuria
|
|
JP6135934B2
(ja)
|
2014-01-22 |
2017-05-31 |
株式会社オートネットワーク技術研究所 |
スイッチング装置
|
|
JP6145145B2
(ja)
|
2014-09-30 |
2017-06-07 |
三ツ星ベルト株式会社 |
ベルト取付治具
|
|
US10195188B2
(en)
|
2016-06-13 |
2019-02-05 |
Chemocentryx, Inc. |
Method of treating pancreatic cancer
|
|
IL294410B2
(en)
*
|
2016-11-23 |
2024-02-01 |
Chemocentryx Inc |
A method for the treatment of focal segmental tuberous sclerosis
|
|
MX386699B
(es)
*
|
2017-10-11 |
2025-03-19 |
Chemocentryx Inc |
Tratamiento de glomerulosclerosis segmentaria focal con antagonistas ccr2
|